Convergent Therapeutics to Announce Clinical Trial Updates on its Lead Candidate at the American Association for Cancer Research (AACR) Annual Meeting 2023
News & media
Convergent Therapeutics Announces Presentations at the 2023 ASCO Genitourinary (GU) Cancers Symposium on its Lead Candidate
Convergent Therapeutics Banking on Radioantibody Approach for PSMA-Targeted mCRPC Treatment
Convergent Therapeutics and IONETIX Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)
NorthStar Medical Radioisotopes and Convergent Therapeutics Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)
Convergent Therapeutics and Point Biopharma Announce a Collaboration to Evaluate CONV01-α (Rosopatamab-225Ac) in combination with PNT2002 for Progressive Metastatic Castration-Resistant Prostate Cancer
Convergent Therapeutics Appoints Alexander Brown as Chief Operating Officer
Convergent Therapeutics Appoints Philip Kantoff, M.D. as Chief Executive Officer